BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21858415)

  • 1. Comparison of radiochemotherapy alone to surgery plus radio(chemo)therapy for non-metastatic stage III/IV squamous cell carcinoma of the head and neck: A matched-pair analysis.
    Rades D; Meyners T; Kazic N; Bajrovic A; Rudat V; Schild SE
    Strahlenther Onkol; 2011 Sep; 187(9):541-7. PubMed ID: 21858415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer.
    Rades D; Stoehr M; Meyners T; Bohlen G; Nadrowitz R; Dunst J; Schild SE; Wroblewski J; Albers D; Schmidt R; Alberti W; Tribius S
    Strahlenther Onkol; 2008 Apr; 184(4):198-205. PubMed ID: 18398584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiochemotherapy versus surgery plus radio(chemo)therapy for stage T3/T4 larynx and hypopharynx cancer - results of a matched-pair analysis.
    Rades D; Schroeder U; Bajrovic A; Schild SE
    Eur J Cancer; 2011 Dec; 47(18):2729-34. PubMed ID: 21726998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck.
    Tribius S; Kronemann S; Kilic Y; Schroeder U; Hakim S; Schild SE; Rades D
    Strahlenther Onkol; 2009 Oct; 185(10):675-81. PubMed ID: 19806333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Simultaneous radiochemotherapy with carboplatin in patients with inoperable advanced stage III and IV head and neck tumors].
    Mücke R; Blynow M; Ziegler PG; Libera T; Kundt G; Dommerich S; Kramp B; Fietkau R
    Strahlenther Onkol; 1999 May; 175(5):213-7. PubMed ID: 10356610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
    Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
    Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of tumor control and presence of visible necrosis in head and neck cancer patients treated with radiotherapy or radiochemotherapy.
    Kuhnt T; Mueller AC; Pelz T; Haensgen G; Bloching M; Koesling S; Schubert J; Dunst J
    J Cancer Res Clin Oncol; 2005 Nov; 131(11):758-64. PubMed ID: 16088405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results.
    Adelstein DJ; Saxton JP; Lavertu P; Tuason L; Wood BG; Wanamaker JR; Eliachar I; Strome M; Van Kirk MA
    Head Neck; 1997 Oct; 19(7):567-75. PubMed ID: 9323144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck.
    Merlano M; Benasso M; Corvò R; Rosso R; Vitale V; Blengio F; Numico G; Margarino G; Bonelli L; Santi L
    J Natl Cancer Inst; 1996 May; 88(9):583-9. PubMed ID: 8609658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor expression: prognostic value in locally advanced squamous cell carcinoma of the head and neck.
    Rades D; Seibold ND; Schild SE; Bruchhage KL; Gebhard MP; Noack F
    Strahlenther Onkol; 2013 Oct; 189(10):849-55. PubMed ID: 23959264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locally advanced stage IV squamous cell carcinoma of the head and neck: impact of pre-radiotherapy hemoglobin level and interruptions during radiotherapy.
    Rades D; Stoehr M; Kazic N; Hakim SG; Walz A; Schild SE; Dunst J
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1108-14. PubMed ID: 17905528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute toxicity of three versus two courses of cisplatin for radiochemotherapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN): a matched pair analysis.
    Rades D; Kronemann S; Meyners T; Schild SE; Hakim SG
    Oral Oncol; 2010 Jul; 46(7):549-52. PubMed ID: 20435508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant and concomitant chemotherapy and radiation therapy in patients with advanced head and neck carcinoma.
    Rinehart J; Ruff T; Cheung A; Hutchinson L; Tuggle R; Pinkston DR; Keville L; Wong L
    Otolaryngol Head Neck Surg; 2005 Jan; 132(1):69-74. PubMed ID: 15632912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiochemotherapy for locally advanced squamous cell carcinoma of the head and neck: Higher-dose cisplatin every 3 weeks versus cisplatin/5-fluorouracil every 4 weeks.
    Rades D; Strojan P; Seidl D; Janssen S; Bajrovic A; Kazic N; Hakim SG; Wollenberg B; Schild SE
    J Craniomaxillofac Surg; 2016 Sep; 44(9):1436-40. PubMed ID: 27499514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The value of qualitative regression grading as a prognostic factor for survival after preoperative radiochemotherapy in patients with advanced head and neck cancer].
    Hermann RM; Krech R; Hartlapp J; Esser E; Christoph B; Müller MK; Wagner W
    Strahlenther Onkol; 2001 Jun; 177(6):277-82. PubMed ID: 11446315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell carcinoma of the head and neck: a comparative study using the intergroup study 0034 and the Radiation Therapy Oncology Group head and neck database.
    Laramore GE; Scott CB; Schuller DE; Haselow RE; Ervin TJ; Wheeler R; al-Sarraf M; Gahbauer RA; Jacobs JR; Schwade JG
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1011-6. PubMed ID: 8262821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Rades D; Seibold ND; Gebhard MP; Noack F; Schild SE; Thorns C
    Strahlenther Onkol; 2011 Oct; 187(10):626-32. PubMed ID: 21932027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of low hemoglobin levels on outcomes of radiotherapy following microscopically complete resection of locally advanced SCCHN: Implications for the future.
    Rades D; Seidl D; Janssen S; Wollenberg B; Hakim SG; Schild SE
    J Craniomaxillofac Surg; 2016 Sep; 44(9):1441-4. PubMed ID: 27470216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo.
    Paccagnella A; Orlando A; Marchiori C; Zorat PL; Cavaniglia G; Sileni VC; Jirillo A; Tomio L; Fila G; Fede A
    J Natl Cancer Inst; 1994 Feb; 86(4):265-72. PubMed ID: 8158680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma.
    Denis F; Garaud P; Bardet E; Alfonsi M; Sire C; Germain T; Bergerot P; Rhein B; Tortochaux J; Calais G
    J Clin Oncol; 2004 Jan; 22(1):69-76. PubMed ID: 14657228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.